These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9730714)

  • 41. [Pathology of chronic renal insufficiency treated with repeated hemodialysis].
    de Werra P
    Rev Med Suisse Romande; 1980 May; 100(5):413-7. PubMed ID: 7455466
    [No Abstract]   [Full Text] [Related]  

  • 42. [Radiography of the hands, with a mammographic technic, in the study and supervision of renal osteodystrophy. Patients undergoing periodic hemodialysis].
    Bedani PL; Tamarozzi R; Farinelli R; Perini L; De Paoli Vitali E; Gilli P; Squerzanti R; Farinelli A
    Minerva Nefrol; 1983; 30(1):43-50. PubMed ID: 6843885
    [No Abstract]   [Full Text] [Related]  

  • 43. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of metacarpal and iliac bone in chronic renal failure: influence of haemodialysis, parathyroid activity, type of renal disease, physical activity and heparin consumption.
    Henderson RG; Russell RG; Earnshaw MJ; Ledingham JG; Oliver DO; Woods CG
    Clin Sci (Lond); 1979 Apr; 56(4):317-24. PubMed ID: 477216
    [No Abstract]   [Full Text] [Related]  

  • 45. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
    McCarley PB; Arjomand M
    Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teaching program effects on high phosphorus levels in patients receiving hemodialysis.
    Schlatter S; Ferrans CE
    ANNA J; 1998 Feb; 25(1):31-6; discussion 37-8. PubMed ID: 9543905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Potentials for the early diagnosis of renal osteodystrophy in patients with chronic kidney failure during treatment by systematic hemodialysis].
    Shcherbakova EO; Fekson EG; Cherniakov VL; Shcherbakov VA
    Urol Nefrol (Mosk); 1985; (2):58-60. PubMed ID: 3992758
    [No Abstract]   [Full Text] [Related]  

  • 48. Vitamin d and stage 5 chronic kidney disease: a new paradigm?
    Heaf JG; Joffe P; Marckmann P
    Semin Dial; 2012; 25(1):50-8. PubMed ID: 21967444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the jaws in chronic renal insufficiency and haemodialysis. Report of a case.
    Söderholm G; Lysell L; Svensson A
    J Clin Periodontol; 1974; 1(1):36-42. PubMed ID: 4532115
    [No Abstract]   [Full Text] [Related]  

  • 50. [The effects of estrogen on renal osteodystrophy in the female patients undergoing maintenance hemodialysis].
    Akino H; Saito A; Maeda S; Kitajima W; Okano M; Isomatsu Y; Muranaka K; Kanimoto Y; Shimizu Y; Kawada Y
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1129-36. PubMed ID: 3807045
    [No Abstract]   [Full Text] [Related]  

  • 51. We Use Too Much Vitamin D in Hemodialysis Patients.
    Reilly RF
    Semin Dial; 2016 Jul; 29(4):320-2. PubMed ID: 27075415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 53. Bone disease in renal failure. Introduction.
    Malluche HH
    Miner Electrolyte Metab; 1991; 17(4):209-10. PubMed ID: 1813782
    [No Abstract]   [Full Text] [Related]  

  • 54. Insulin-like growth factor 1 and 2 serum concentrations in dialysis patients with secondary hyperparathyroidism and adynamic bone disease.
    Weinreich T; Zapf J; Schmidt-Gayk H; Ritzel H; Delling G; Reichel H
    Clin Nephrol; 1999 Jan; 51(1):27-33. PubMed ID: 9988143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Renal osteodystrophy and its possible correction in patients on chronic hemodialysis].
    Rozental' RL; Babarykin DA; Tikhomirova TE; Il'inskiĭ IM; Chernevskis KhK
    Ter Arkh; 1986; 58(1):105-8. PubMed ID: 3961679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is renal osteodystrophy rare in the tropics?
    Youmbissi TJ; Ndi OR; Gonsu JF; Ngu JL; Blackett-Ngu K; Mbakop A
    Nephron; 1990; 55(2):227-8. PubMed ID: 2362644
    [No Abstract]   [Full Text] [Related]  

  • 57. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
    Bagon J; Brunfaut C
    J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994
    [No Abstract]   [Full Text] [Related]  

  • 58. Preventing bone disease requires diligent management in patients with renal failure.
    Kolb FO
    West J Med; 1994 May; 160(5):475-7. PubMed ID: 8048242
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rib fractures as the 1st clinical x-ray manifestation of renal osteodystrophy during hemodialysis treatment].
    Kulakov GP; Shotemor ShSh; Tret'iakov AE
    Vestn Rentgenol Radiol; 1980; (3):5-8. PubMed ID: 7395035
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hexa-calcium-hexa-sodium-hepta-citrate hydrate complex for prophylaxis and treatment of renal osteopathy in chronic hemodialysis].
    Albert FW; Schmidt U; Schäfer K
    Med Welt; 1973 Feb; 24(5):185-7. PubMed ID: 4805391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.